Asunto(s)
Broncoscopía , Atelectasia Pulmonar , Enfermedad de Tay-Sachs , Humanos , Broncoscopía/métodos , Insuflación/métodos , Atelectasia Pulmonar/diagnóstico por imagen , Atelectasia Pulmonar/etiología , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/complicaciones , Ultrasonografía Intervencional/métodosRESUMEN
PURPOSE: Late-onset Tay-Sachs disease (LOTS) is a form of GM2 gangliosidosis, an autosomal recessive neurodegenerative disorder characterized by slowly progressive cerebellar ataxia, lower motor neuron disease, and psychiatric impairment due to mutations in the HEXA gene. The aim of our work was to identify the characteristic brain MRI findings in this presumably underdiagnosed disease. METHODS: Clinical data and MRI findings from 16 patients (10F/6 M) with LOTS from two centers were independently assessed by two readers and compared to 16 age- and sex-related controls. RESULTS: Lower motor neuron disease (94%), psychiatric symptoms-psychosis (31%), cognitive impairment (38%) and depression (25%)-and symptoms of cerebellar impairment including dysarthria (94%), ataxia (81%) and tremor (69%), were the most common clinical features. On MRI, pontocerebellar atrophy was a constant finding. Compared to controls, LOTS patients had smaller mean middle cerebellar peduncle diameter (p < 0.0001), mean superior cerebellar peduncle diameter (p = 0.0002), mesencephalon sagittal area (p = 0.0002), pons sagittal area (p < 0.0001), and larger 4th ventricle transversal diameter (p < 0.0001). Mild corpus callosum thinning (37.5%), mild cortical atrophy (18.8%), and white matter T2 hyperintensities (12.5%) were also present. CONCLUSION: Given the characteristic clinical course and MRI findings of the pontocerebellar atrophy, late-onset Tay-Sachs disease should be considered in the differential diagnosis of adult-onset cerebellar ataxias.
Asunto(s)
Enfermedades Cerebelosas , Gangliosidosis GM2 , Enfermedad de la Neurona Motora , Enfermedad de Tay-Sachs , Adulto , Atrofia , Humanos , Enfermedades de Inicio Tardío , Imagen por Resonancia Magnética , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/genéticaRESUMEN
OBJECTIVE: Our study aimed to quantify structural changes in relation to metabolic abnormalities in the cerebellum, thalamus, and parietal cortex of patients with late-onset GM2-gangliosidosis (LOGG), which encompasses late-onset Tay-Sachs disease (LOTS) and Sandhoff disease (LOSD). METHODS: We enrolled 10 patients with LOGG (7 LOTS, 3 LOSD) who underwent a neurological assessment battery and 7 age-matched controls. Structural MRI and MRS were performed on a 3 T scanner. Structural volumes were obtained from FreeSurfer and normalized by total intracranial volume. Quantified metabolites included N-acetylaspartate (NAA), choline (Cho), myo-inositol (mI), creatine (Cr), and combined glutamate-glutamine (Glx). Metabolic concentrations were corrected for partial volume effects. RESULTS: Structural analyses revealed significant cerebellar atrophy in the LOGG cohort, which was primarily driven by LOTS patients. NAA was lower and mI higher in LOGG, but this was also significantly driven by the LOTS patients. Clinical ataxia deficits (via the Scale for the Assessment and Rating of Ataxia) were associated with neuronal injury (via NAA), neuroinflammation (via mI), and volumetric atrophy in the cerebellum. INTERPRETATION: The decrease of NAA in the cerebellum suggests that, in addition to cerebellar atrophy, there is ongoing impaired neuronal function and/or loss, while an increase in mI indicates possible neuroinflammation in LOGG (more so within the LOTS subvariant). Quantifying cerebellar atrophy in relation to neurometabolic differences in LOGG may lead to improvements in assessing disease severity, progression, and pharmacological efficacy. Lastly, additional neuroimaging studies in LOGG are required to contrast LOTS and LOSD more accurately.
Asunto(s)
Gangliosidosis GM2/diagnóstico por imagen , Gangliosidosis GM2/fisiopatología , Enfermedades de Inicio Tardío/diagnóstico por imagen , Enfermedades de Inicio Tardío/fisiopatología , Imagen por Resonancia Magnética/métodos , Análisis Espectral/métodos , Adulto , Cerebelo/diagnóstico por imagen , Cerebelo/patología , Estudios de Cohortes , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Lóbulo Parietal/diagnóstico por imagen , Lóbulo Parietal/patología , Enfermedad de Sandhoff/diagnóstico por imagen , Enfermedad de Sandhoff/fisiopatología , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/fisiopatología , Tálamo/diagnóstico por imagen , Tálamo/patología , Adulto JovenRESUMEN
OBJECTIVE: GM2 gangliosidoses are lysosomal diseases due to biallelic mutations in the HEXA (Tay-Sachs disease [TS]) or HEXB (Sandhoff disease [SD]) genes, with subsequent low hexosaminidase(s) activity. Most patients have childhood onset, but some experience the first symptoms during adolescence/adulthood. This study aims to clarify the natural history of adult patients with GM2 gangliosidosis. METHODS: We retrospectively described 12 patients from a French cohort and 45 patients from the literature. RESULTS: We observed 4 typical presentations: (1) lower motoneuron disorder responsible for proximal lower limb weakness that subsequently expanded to the upper limbs, (2) cerebellar ataxia, (3) psychosis and/or severe mood disorder (only in the TS patients), and (4) a complex phenotype mixing the above 3 manifestations. The psoas was the first and most affected muscle in the lower limbs, whereas the triceps and interosseous were predominantly involved in the upper limbs. A longitudinal study of compound motor action potentials showed a progressive decrease in all nerves, with different kinetics. Sensory potentials were sometimes abnormally low, mainly in the SD patients. The main brain magnetic resonance imaging feature was cerebellar atrophy, even in patients without cerebellar symptoms. The prognosis was mainly related to gait disorder, as we showed that beyond 20 years of disease evolution, half of the patients were wheelchair users. INTERPRETATION: Improved knowledge of GM2 gangliosidosis in adults will help clinicians achieve correct diagnoses and better inform patients on the evolution and prognosis. It may also contribute to defining proper outcome measures when testing emerging therapies. ANN NEUROL 2020;87:609-617.
Asunto(s)
Enfermedad de Sandhoff/fisiopatología , Enfermedad de Tay-Sachs/fisiopatología , Potenciales de Acción , Adolescente , Adulto , Edad de Inicio , Anciano , Atrofia , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Cerebelo/diagnóstico por imagen , Cerebelo/patología , Niño , Disfunción Cognitiva/fisiopatología , Disfunción Cognitiva/psicología , Estudios de Cohortes , Trastornos de Deglución/fisiopatología , Progresión de la Enfermedad , Disartria/fisiopatología , Distonía/fisiopatología , Electrodiagnóstico , Electromiografía , Femenino , Ataxia de la Marcha/fisiopatología , Gangliosidosis GM2/diagnóstico por imagen , Gangliosidosis GM2/fisiopatología , Gangliosidosis GM2/psicología , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Enfermedad de la Neurona Motora/fisiopatología , Espasticidad Muscular/fisiopatología , Debilidad Muscular/fisiopatología , Conducción Nerviosa , Enfermedad de Sandhoff/diagnóstico por imagen , Enfermedad de Sandhoff/psicología , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/psicología , Adulto JovenRESUMEN
BACKGROUND: Tay-Sachs disease (TSD) is an inherited neurodegenerative disorder caused by a lysosomal ß-hexosaminidase A deficiency due to mutations in the HEXA gene. The late-onset form of disease (LOTS) is considered rare, and only a limited number of cases have been reported. The clinical course of LOTS differs substantially from classic infantile TSD. METHODS: Comprehensive data from 14 Czech patients with LOTS were collated, including results of enzyme assays and genetic analyses. RESULTS: 14 patients (9 females, 5 males) with LOTS were diagnosed between 2002 and 2018 in the Czech Republic (a calculated birth prevalence of 1 per 325,175 live births). The median age of first symptoms was 21 years (range 10-33 years), and the median diagnostic delay was 10.5 years (range 0-29 years). The main clinical symptoms at the time of manifestation were stammering or slurred speech, proximal weakness of the lower extremities due to anterior horn cell neuronopathy, signs of neo- and paleocerebellar dysfunction and/or psychiatric disorders. Cerebellar atrophy detected through brain MRI was a common finding. Residual enzyme activity was 1.8-4.1% of controls. All patients carried the typical LOTS-associated c.805G>A (p.Gly269Ser) mutation on at least one allele, while a novel point mutation, c.754C>T (p.Arg252Cys) was found in two siblings. CONCLUSION: LOTS seems to be an underdiagnosed cause of progressive distal motor neuron disease, with variably expressed cerebellar impairment and psychiatric symptomatology in our group of adolescent and adult patients. The enzyme assay of ß-hexosaminidase A in serum/plasma is a rapid and reliable tool to verify clinical suspicions.
Asunto(s)
Cerebelo/diagnóstico por imagen , Trastornos Mentales/diagnóstico por imagen , Atrofia Muscular/diagnóstico por imagen , Enfermedad de Tay-Sachs/diagnóstico por imagen , Adolescente , Adulto , Edad de Inicio , Estudios de Cohortes , República Checa/epidemiología , Femenino , Humanos , Masculino , Trastornos Mentales/epidemiología , Trastornos Mentales/psicología , Persona de Mediana Edad , Atrofia Muscular/epidemiología , Atrofia Muscular/psicología , Enfermedad de Tay-Sachs/epidemiología , Enfermedad de Tay-Sachs/psicología , Adulto JovenAsunto(s)
Enfermedad de Tay-Sachs/diagnóstico , Ganglios Basales/diagnóstico por imagen , Ganglios Basales/patología , Preescolar , Colombia , Femenino , Hexosaminidasa A/sangre , Hexosaminidasas/sangre , Humanos , Lactante , Imagen por Resonancia Magnética , Vaina de Mielina/patología , Enfermedad de Tay-Sachs/sangre , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/patologíaRESUMEN
Tay-Sachs disease (TSD) is a fatal neurodegenerative disorder caused by a deficiency of the enzyme hexosaminidase A (HexA). TSD also occurs in sheep, the only experimental model of TSD that has clinical signs of disease. The natural history of sheep TSD was characterized using serial neurological evaluations, 7 Tesla magnetic resonance imaging, echocardiograms, electrodiagnostics, and cerebrospinal fluid biomarkers. Intracranial gene therapy was also tested using AAVrh8 monocistronic vectors encoding the α-subunit of Hex (TSD α) or a mixture of two vectors encoding both the α and ß subunits separately (TSD α + ß) injected at high (1.3 × 1013 vector genomes) or low (4.2 × 1012 vector genomes) dose. Delay of symptom onset and/or reduction of acquired symptoms were noted in all adeno-associated virus-treated sheep. Postmortem evaluation showed superior HexA and vector genome distribution in the brain of TSD α + ß sheep compared to TSD α sheep, but spinal cord distribution was low in all groups. Isozyme analysis showed superior HexA formation after treatment with both vectors (TSD α + ß), and ganglioside clearance was most widespread in the TSD α + ß high-dose sheep. Microglial activation and proliferation in TSD sheep-most prominent in the cerebrum-were attenuated after gene therapy. This report demonstrates therapeutic efficacy for TSD in the sheep brain, which is on the same order of magnitude as a child's brain.
Asunto(s)
Dependovirus , Terapia Genética , Enfermedad de Tay-Sachs/terapia , Cadena alfa de beta-Hexosaminidasa/biosíntesis , Cadena beta de beta-Hexosaminidasa/biosíntesis , Animales , Encéfalo/diagnóstico por imagen , Encéfalo/enzimología , Modelos Animales de Enfermedad , Ecocardiografía , Humanos , Imagen por Resonancia Magnética , Microglía/enzimología , Ovinos , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/enzimología , Enfermedad de Tay-Sachs/genética , Cadena alfa de beta-Hexosaminidasa/genética , Cadena beta de beta-Hexosaminidasa/genéticaRESUMEN
Variant B1 is a rare type of GM2 gangliosidosis. Clinically, it shows a wide spectrum of forms ranging from infantile to juvenile. We report the first magnetic resonance imaging (MRI) findings from three patients affected by GM2 gangliosidosis variant B1, two presenting with the infantile form and one with the juvenile form. The MRI appearances of the two patients with the infantile form disease are congruent with those reported for the early-onset type of both Tay-Sachs and Sandhoff diseases, and are characterized by early involvement of the basal ganglia and thalamus with cortical atrophy appearing later. In contrast, the patient with the juvenile form of variant B1 showed progressive cortical and white-matter atrophy of the supratentorial structures and, to a lesser extent, the infratentorial structures. No basal ganglia or thalamic anomalies were observed. Because in the adult forms of both Tay-Sachs and Sandhoff diseases a progressive cerebellar atrophy represents the only abnormality detectable, it appears that an MRI pattern peculiar to GM2 gangliosidosis can be defined. This pattern ranges from the basal ganglia injury associated with the early and severe demyelination process noted in the infantile form of the disease, to cerebellar atrophy with no supratentorial anomalies in the adult form. An "intermediate" MRI picture, with cortical atrophy and mild cerebellar atrophy, but without basal ganglia impairment, can be observed in the juvenile form. In addition, our investigations suggest that MRI abnormalities in GM2 gangliosidosis correlate with the clinical form of the disease rather than with the biochemical variant of the enzymatic defect.
Asunto(s)
Encéfalo/diagnóstico por imagen , Encéfalo/patología , Gangliosidosis GM2/diagnóstico por imagen , Gangliosidosis GM2/patología , Variación Genética , Factores de Edad , Niño , Preescolar , Femenino , Gangliosidosis GM2/genética , Gangliosidosis GM2/fisiopatología , Humanos , Lactante , Imagen por Resonancia Magnética , Masculino , Radiografía , Enfermedad de Sandhoff/diagnóstico por imagen , Enfermedad de Sandhoff/genética , Enfermedad de Sandhoff/patología , Enfermedad de Sandhoff/fisiopatología , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/genética , Enfermedad de Tay-Sachs/patología , Enfermedad de Tay-Sachs/fisiopatología , beta-N-Acetilhexosaminidasas/deficienciaRESUMEN
OBJECTIVE: MR and CT findings in two patients of Tay-Sachs disease are reported. MATERIALS AND METHODS: In two patients of Tay-Sachs disease, MR and CT studies were conducted in the early phase (11 and 10 months of age, respectively) and one was followed-up with MR in the late phase at the age of 5 years and 8 months. Six MR studies on this disease (including 3 other cases documented in the literature) were reviewed and correlated with the pathological phases of this disease. RESULTS: MRI findings drastically changed during the phases of disease process in one case. In the early phase, T2-weighted MR images demonstrated hyperintensity in both basal ganglia and thalamus. MR images obtained in the late phase demonstrated markedly advanced brain atrophy and diffuse white matter lesions, which were hyperintense on the T2-weighted images. T1-weighted images exhibited hyperintensity in the basal ganglia, thalamus, and along the cortical layer of the cerebrum, which appeared to by hypointense on T2-weighted images. CONCLUSION: MR was apparently superior to CT in clearly delineating lesions of this disease. These abnormal signal intensities in the late phase may reflect the pathological findings, marked accumulation of GM2 ganglioside in the basal ganglia and thalamus and along the cerebral gray matter.
Asunto(s)
Imagen por Resonancia Magnética , Enfermedad de Tay-Sachs/patología , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Femenino , Humanos , Lactante , Masculino , Enfermedad de Tay-Sachs/diagnóstico , Enfermedad de Tay-Sachs/diagnóstico por imagen , Tomografía Computarizada por Rayos XRESUMEN
After the introduction of 4-methylumbelliferyl-2-acetamido-2-deoxy-beta A-D-glucopyranoside (4MUG) and its sulfated form (4MUGS) in the pre- and postnatal diagnosis and carrier identification of gangliosidosis genotypes, infrequent forms of the GM2 gangliosidosis Type B (Tay-Sachs disease) have been observed which show normal activity of Hexosaminidase A (Hex A) isoenzyme with the substrate 4MUG but absent or deficient activity against the sulfated form 4MUGS. Here we report the observation of a German/Hungarian boy aged 12 when he died with a prolonged course of a neurodegenerative disorder, later biochemically identified as a GM2 gangliosidosis B1-variant which is characterized by a deficient Hex A activity only against 4MUGS. The first clinical symptoms had occurred after the age of 14 months with a clear manifestation of the disease at age 3, when he presented disturbances of movement and tended to fall down. The slowly progressive course with brain atrophy, seizures and severe mental deterioration resulted in death after almost 9 years. At autopsy, the typical light microscopic neuronal changes of a "lysosomal storage disorder" were found, with multilamellar concentric bodies (MCB) and Zebra bodies in the neuronal cytoplasm at the electron microscopic level.
Asunto(s)
Enfermedad de Tay-Sachs/genética , Encéfalo/patología , Estudios de Seguimiento , Genotipo , Alemania , Humanos , Hungría/etnología , Lactante , Enfermedades por Almacenamiento Lisosomal/patología , Masculino , Enfermedad de Tay-Sachs/diagnóstico por imagen , Enfermedad de Tay-Sachs/patología , Tomografía Computarizada por Rayos XRESUMEN
In 13 patients, the GM2 gangliosidoses, Sandhoff disease and Tay-Sachs disease, were found to be constantly associated with homogeneously and symmetrically increased CT attenuation within the thalami. In the only patient examined with MR imaging, a T2-weighted sequence showed hypointense thalami. It is suggested that this finding is caused by an accumulation of calcium, associated with the intracellular storage of GM2 ganglioside. The finding of dense thalami may be useful as a specific diagnostic criterion for GM2 gangliosidoses. In a few patients with blocks in adjacent steps in the sphingolipid metabolism, this finding was not present.
Asunto(s)
Enfermedad de Sandhoff/diagnóstico por imagen , Enfermedad de Tay-Sachs/diagnóstico por imagen , Tálamo/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Femenino , Humanos , Lactante , Masculino , Enfermedad de Sandhoff/patología , Enfermedad de Tay-Sachs/patología , Tálamo/patologíaRESUMEN
An autopsy case of a 3-year-old female infant with Tay-Sachs disease was presented. A cherry red spot in the fundus and a deficiency of N-acetyl-beta-hexosaminidase A in the white blood cells were revealed soon after admission at the age of one year. Her parents and sister were found to be healthy carriers. The patient showed a typical clinical course with marked cranial swelling. In addition to the marked ballooning of neurons on light microscope, membranous cytoplasmic body (MCB) on electron microscope and abnormal accumulation of GM2 ganglioside in the cerebral cortex by thin layer chromatography were confirmed in the autopsy specimens. In the late stage of her clinical course, the cranial computerized tomography (CT) demonstrated symmetric and deep-wavy hyperdense cerebral cortical zones, diffuse hypodensity and diminished volume of cerebral white matter, mild to moderate ventricular dilatation, and a small cerebellum and brainstem. These conspicuous appearances of the cranial CT seem to be characteristic of Tay-Sachs disease in the late stage, and they are derived from abnormal accumulation of GM2 ganglioside in the cerebral cortex, and diffuse intense demyelination (dysmyelinating demyelination) of the cerebral white matter.